Concurrent administration of serotonergic antidepressants and ozanimod in participants with relapsing multiple sclerosis from the open-label extension DAYBREAK trial

Authors

Robert T Naismith, Washington University School of Medicine in St. Louis
Jeffrey A Cohen, Cleveland Clinic
Amit Bar-Or, University of Pennsylvania
Giancarlo Comi, Vita-Salute San Raffaele University
Krzysztof W Selmaj, University of Warmia and Mazury in Olsztyn
Hans-Peter Hartung, Heinrich-Heine University Düsseldorf
James K Sheffield, Bristol Myers Squibb
Anthony Krakovich, Bristol Myers Squibb
Daniel Tatosian, Bristol Myers Squibb
Chun-Yen Cheng, Bristol Myers Squibb
Jennifer Reardon, Bristol Myers SquibbBristol Myers Squibb
Vadim Khaychuk, Bristol Myers Squibb
Jon V Riolo, Bristol Myers Squibb
Diego Silva, Bristol Myers Squibb
Bruce Ac Cree, University of California San Francisco

Journal

Multiple Sclerosis Journal

Publication Date

2-1-2024

Volume

30

Issue

2

First Page

177

Last Page

183

Document Type

Open Access Publication

DOI

10.1177/13524585231216854

Rights and Permissions

Naismith RT, Cohen JA, Bar-Or A, Comi G, Selmaj KW, Hartung HP, Sheffield JK, Krakovich A, Tatosian D, Cheng CY, Reardon J, Khaychuk V, Riolo JV, Silva D, Cree BA. Concurrent administration of serotonergic antidepressants and ozanimod in participants with relapsing multiple sclerosis from the open-label extension DAYBREAK trial. Mult Scler. 2024 Feb;30(2):177-183. doi: 10.1177/13524585231216854. © The Author(s), 2023. Creative Commons License (CC BY-NC 4.0) This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). Request permissions for this article.

Recommended Citation

Naismith, Robert T; Cohen, Jeffrey A; Bar-Or, Amit; Comi, Giancarlo; Selmaj, Krzysztof W; Hartung, Hans-Peter; Sheffield, James K; Krakovich, Anthony; Tatosian, Daniel; Cheng, Chun-Yen; Reardon, Jennifer; Khaychuk, Vadim; Riolo, Jon V; Silva, Diego; and Cree, Bruce Ac, "Concurrent administration of serotonergic antidepressants and ozanimod in participants with relapsing multiple sclerosis from the open-label extension DAYBREAK trial." Multiple Sclerosis Journal. 30, 2. 177 - 183. (2024).
https://digitalcommons.wustl.edu/oa_4/3238

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.